Page last updated: 2024-11-08

niadenate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

niadenate: prodrug of nicotinic acid & tiadenol; structure given in second source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID181712
SCHEMBL ID3078994
MeSH IDM0111269

Synonyms (7)

Synonym
82601-22-7
niadenate
3-pyridinecarboxylic acid, 1,10-decanediylbis(thio-2,1-ethanediyl) ester
41891-94-5
SCHEMBL3078994
[(decane-1,10-diyl)bis(sulfanediyl)ethane-2,1-diyl] dipyridine-3-carboxylate
DTXSID30962041
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]